PROG NASDAQ
Biora Therapeutics, Inc.
1W: +5.7%
1M: -26.9%
3M: -42.2%
1Y: -67.5%
$0.88
Last traded 2022-05-06 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$1M
Revenue
-98.3% YoY
$-202M
Net Income
+2.7% YoY
$-144M
Free Cash Flow
+23.5% YoY
100.0%
Gross Margin
-15484.1%
Op. Margin
-10962.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE184.7%
ROA-187.6%
ROIC440.3%
Valuation
P/E-0.1
P/B-0.3
EV/EBITDA-1.4
Leverage
Debt/Equity-1.39
Current Ratio1.61
Interest Cov.-24.3x
Quality Scores
Piotroski F3/9
Altman Z-17.72
Beneish M-22.35